Drugs & Pharmaceuticals M&A » By The Online Investor Staff, updated Thu., Apr. 18, 10:17 AM
Recent mergers and acquisitions in the Drugs & Pharmaceuticals M&A category.
| This Slide: #40 of 100 |
Slide #40. McKesson Corporation — Celesio
Acquirer:
McKesson Corporation (NYSE:MCK)
Acquiree:
Celesio
Details:
McKesson Corporation (NYSE:MCK), a leading North American healthcare services and information technology company, announced today that it has reached an agreement with Franz Haniel & Cie. GmbH ("Haniel") to acquire their entire holding of Celesio shares for EUR 23.50 per share. In a separate and subsequent agreement, McKesson also announced the acquisition of Celesio convertible bonds from Elliott. These agreements are not subject to any closing conditions and the transactions are expected to close within 10 business days. After the close of the agreements with Haniel and Elliott, McKesson will exceed 75% ownership of Celesio shares on a fully diluted basis.
McKesson is engaged in healthcare services. Co. operates its business in four reportable segments: U.S. Pharmaceutical, which distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; Prescription Technology Solutions, which provides prescription price transparency, benefit insight, dispensing support services, third-party logistics, and wholesale distribution support; Medical-Surgical Solutions, which provides medical-surgical supply distribution, logistics, and other services to healthcare providers; and International, which provides distribution and services to wholesale, institutional, and retail customers.
McKesson SEC Filing Email Alerts Service
Open the MCK Page at The Online Investor »
|
|||||||||||||||||||||
Open the MCK Page at The Online Investor (in a new window) »
 Free MCK Email Alerts:
Get SEC Filing Alerts Get Dividend Alerts 
|
Avg. Broker Rec.
 
|
Strong Buy (3.57 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Analysts' Target Price: MCK Stock Forecast Based on Zacks ABR data; powered by Xignite |
